Page last updated: 2024-09-05

regadenoson and Arteriosclerosis, Coronary

regadenoson has been researched along with Arteriosclerosis, Coronary in 82 studies

Research

Studies (82)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (7.32)29.6817
2010's55 (67.07)24.3611
2020's21 (25.61)2.80

Authors

AuthorsStudies
Ahmed, AI; Al-Mallah, MH; Alahdab, F; El Nihum, LI; Han, Y; Nabi, F; Saad, JM1
Bromberger, B; Brzezinski, M; Calabrese, DR; Kukreja, J1
Fahed, AC; Grewal, S; Osborne, MT; Qamar, I; Tawakol, A; Weiner, R1
Dugan, E; Jaber, WA; Parizher, G1
Bartenstein, P; Bauer, M; Behr, J; Huber, BC; Kneidinger, N; Leuschner, G; Massberg, S; Milger, K; Munker, D; Neurohr, C; Schiopu, SRI; Todica, A; Zacherl, M1
Ahmed, A; Ahmed, D; Al-Mallah, M; Alali Alfaris, M; Alharthi, M; Aljizeeri, A; Alsaileek, A; Elneama, A; Farea, J; Suliman, I1
Reyes, E; Richard Underwood, S1
Bayer, RR; De Cecco, CN; Duguay, TM; Jacobs, BE; Johnson, AA; Litwin, SE; Nance, JW; Schoepf, UJ; Suranyi, P; Tesche, C; van Assen, M; Varga-Szemes, A1
Demkow, M; Kępka, C; Kruk, M; Marczak, M; Miłosz-Wieczorek, B; Oleksiak, A; Śpiewak, M1
Araujo Silva, B; Bortolotto, AL; Gervino, EV; Hauser, TH; Marum, AA; Medeiros, SA; Nearing, BD; Pedreira, GC; Tessarolo Silva, F; Verrier, RL1
Arif, AW; Doukky, R; Khan, MS1
Kero, T; Knuuti, J; Lagerqvist, B; Lubberink, M; Pikkarainen, E; Saraste, A; Sörensen, J1
Caobelli, F; Clerc, OF; Frey, SM; Haaf, P; Honegger, U; Zellweger, MJ1
Ananthasubramaniam, K; Kitt, TM; Kristy, RM; Saval, M; Spalding, JR; Van Harn, M; Xu, Y1
Adluru, G; Bieging, ET; Chang, L; DiBella, E; Haider, I; Jensen, L; Likhite, D; McGann, CJ; Shaaban, A; Suksaranjit, P; Wilson, BD1
Kaandorp, TAM; Kuijpers, D; Oudkerk, M; van der Harst, P; van Dijk, R; van Dijkman, PRM; Vliegenthart, R1
Howe, C; Kumar, G; Lee, JZ; Lee, KS; Low, SW; Nguyen, T; Nyotowidjojo, I; Pinto, D; Singh, N1
Andrikopoulou, E; Bajaj, NS; Brice, L; Doppalapudi, H; Hage, FG; Iskandrian, AE; Morgan, CJ1
Balfour, PC; Bourque, J; Epstein, FH; Gonzalez, JA; Kramer, CM; Kuruvilla, S; Mathew, R; Meyer, CH; Pan, J; Salerno, M; Shaw, PW; Taylor, AM; Yang, Y; Zorach, B1
Gebker, R; Hireche-Chikaoui, H; Kelle, S; Pieske, B; Schnackenburg, B; Stoiber, L1
Arai, AE; Chen, MY; Conn, HM; Greve, AM; Hsu, LY; Patricia Bandettini, W; Shanbhag, SM; Ta, AD; Winkler, S1
Cao, JJ; David Cooke, C; Nichols, KJ; Palestro, CJ; Van Tosh, A; Votaw, JR1
Bönner, F; Heimann, M; Jung, C; Kelm, M; Lachmann, V; Verde, PE; Zeus, T1
El Accaoui, R; Gnanaraj, J; Jayamani Roshan, S; Shetty, S1
Akçakaya, M; Chen, KA; Farzaneh-Far, A; Hughes, A; Kazmirczak, F; Martin, CM; Nijjar, PS; Okasha, O; Shenoy, C; Zhang, L1
Auerbach, A; Chan, N; Delphin, J; Kataria, V; Makaryus, JN1
Gandhi, H; Goldberg, Y; Hasani, A; Mustehsan, MH; Rashid, SMI1
Ahlberg, AW; Alter, EL; Duvall, WL; Felpel, KD; Gowdar, S; Henzlova, MJ; Perucki, WH; Rai, M; Savino, JA1
Cremer, PC; Harb, SC; Jaber, WA; Mentias, A; Meredith, D; Xu, B1
Chan, N; Kataria, V; Kim, BS; Makaryus, JN; Raimondi, P1
Evans, K; Farzaneh-Far, A; Kwong, RY; Romano, S; Romer, B; Shenoy, C; Trybula, M1
Belcik, JT; Davidson, BP; Fazio, S; Ferencik, M; Layoun, M; Lindner, JR; Moccetti, F; Raber, J; Taqui, S; Tavori, H; Turker, M1
Al Badarin, F; Bateman, TM; Case, JA; Chan, PS; Courter, S; Heller, GV; Kennedy, KF; McGhie, AI; Patel, KK; Spertus, JA1
Doan, TT; Loar, RW; Masand, PM; Noel, CV; Pednekar, AS; Wilkinson, JC1
Aulwes, D; Gupta, D; Holly, TA; Montero, K; Ross, MI; Shen, S; Wilkins, JT; Wu, E1
Ali, B; Ali, T; Blankstein, R; Bruyere, J; Di Carli, MF; Dorbala, S; Hsiao, E; Kwong, RY; Skali, H1
Bhave, NM; Cavanaugh, KP; Chandra, S; Czobor, P; Davidson, MH; Freed, BH; Lang, RM; Mor-Avi, V; Narang, A; Patel, AR; Tanaka, SM; Turner, KM; Zaran, ER1
Alam, M; Ananthasubramaniam, K; Boedeker, S; Brooks, K; Iyer, H; Khandelwal, A; Nguyen, P; Saad, H; Shaikh, K; Wang, DD1
Doukky, R; Golzar, Y1
Cohen, M; Dunn, T; Mooney, D; Rosenblatt, J1
Hage, FG1
Cerqueira, MD; Cremer, PC; Jaber, WA; Khalaf, S; Lou, J; Rodriguez, L1
Bayer, RR; De Cecco, CN; Harris, BS; Krazinski, AW; McWhite, CB; Meinel, FG; Schoepf, UJ; Silverman, JR1
Hage, FG; Iskandrian, AE1
Bateman, TM; Cerqueira, MD; Iskandrian, AE; Mahmarian, JJ; Nabi, F; Peterson, LE; Thomas, GS; Xu, J1
Amano, T; Doh, JH; Kato, D; Kim, HS; Koo, BK; Kurita, A; Lim, WH; Nam, CW; Oi, M; Park, JJ; Park, KW; Pijls, NH; Takashima, H; Toyofuku, M; van Nunen, L; Waseda, K; Yang, HM1
Bleich, S; El-Hajj, S; Ghimire, G; Hage, FG; Iskandrian, AE; Lester, D; Mckay, J1
Doukky, R; Dua, SG; Gidea, C; Golzar, J; Golzar, Y; Olusanya, A; Pe, N1
Borges-Neto, S; Dunning, A; Farzaneh-Far, A; O'Connor, CM; Oldan, JD; Shaw, LK1
AlJaroudi, WA; Bleich, S; El-Hajj, S; Farag, A; Hage, FG; Iskandrian, AE; Manaoragada, P1
Acampa, W; Anagnostopoulos, C; Ballinger, J; Bengel, F; Buechel, RR; Cuocolo, A; De Bondt, P; de Wit, TC; Flotats, A; Hacker, M; Hesse, B; Hindorf, C; Kaufmann, PA; Lindner, O; Ljungberg, M; Lonsdale, M; Manrique, A; Minarik, D; Scholte, AJ; Slart, RH; Trägårdh, E; van Eck-Smit, BL; Verberne, HJ1
Abdelmoneim, SS; Adolphson, M; Huang, R; Kirby, B; Mulvagh, SL; Nhola, LF; O'Leary, E; Omer, MA; Porter, TR; Warta, SJ; Xie, F1
Bonyadlou, S; Huang, HW; Mehra, A; Qamruddin, S; Yoon, AJ1
Bourque, JM; Löffler, AI1
Bordenave, L; Douard, H; Janvier, L; Karcher, G; Pinaquy, J1
Ali, A; Campagnoli, T; Doukky, R; Fughhi, I; Wassouf, M1
Reyes, E1
Aarøe, J; Eggert Jensen, S; Pape, M; Petersen, LJ; Zacho, HD1
AlJaroudi, WA; Andrikopoulou, E; Farag, A; Hage, FG; Iskandrian, AE; Lester, D; Patel, H1
Abdallah, M; Dwivedi, A; Gerson, MC; Jameria, ZA; Kalakota, N; Khaleghi, M; Khan, N; Washburn, E1
Berman, D; Brodov, Y; Fish, M; Gerlach, J; Germano, G; Gransar, H; Lemley, M; Otaki, Y; Rubeaux, M; Slomka, P1
Bauml, MA; Chung, J; Farzaneh-Far, A; Jue, J; McGraw, S; Romano, S1
Cascino, T; Corbett, JR; Ficaro, EP; Ghannam, M; Konerman, M; Lazarus, JJ; McLaughlin, VV; Mikhova, K; Moles, VM; Murthy, VL; Saleh, A; Weinberg, RL; Yun, HJ1
Ananthasubramaniam, K; Cullom, SJ; Feaheny, KM; Gropler, RJ; Jain, D; Kitt, TM; Thomas, GS; Thompson, RC1
Buhr, C; Eggebrecht, H; Erbel, R; Gössl, M1
Druz, RS1
Bateman, TM; Cerqueira, MD; Hendel, RC; Iskandrian, AE; Mahmarian, JJ; Moye, LA; Olmsted, AW; Thomas, GS1
Al Jaroudi, W; Iskandrian, AE1
Curran, MP; Garnock-Jones, KP1
Aljaroudi, W; Bhambhvani, P; Heo, J; Iqbal, F; Iskandrian, AE; Koneru, J1
Franks, B; Iskandrian, AE; McNutt, BE; Tejani, FH; Thompson, RC1
Ananthasubramaniam, K; Bukofzer, S; Feaheny, K; Klauke, B; McNutt, B; Weiss, R1
Ahmado, I; Flynn, J; Gurm, GS; Sidhu, MS; Uthamalingam, S1
Giedd, KN; Katz, JS; Rachko, M; Ruisi, M1
Frost, L; Hendel, RC1
Ahlberg, AW; Ardestani, A; Barmpouletos, D; Borer, SM; Cyr, G; Heller, GV; Iyah, GS; Katten, DM; Mathur, S; Morales, DC; Parker, MW; Slim, HB1
AlJaroudi, WA; Alraies, MC; Cerquiera, MD; Jaber, WA1
Ghimire, G; Hage, FG; Heo, J; Iskandrian, AE1
Al-Amoodi, M; Bateman, TM; Bybee, KA; Iain McGhie, A; Kennedy, KF; O'Keefe, JH; Oakes, L; Patil, H; Thomas, GS; Thompson, EC; Thompson, RC1
Boulanger, L; Friedman, M; Gatt, E; Kothari, S; Spalding, J; Wu, Y1
Cerqueira, MD1
Eggbrecht, H; Gössl, M1

Reviews

9 review(s) available for regadenoson and Arteriosclerosis, Coronary

ArticleYear
Comparison of regadenoson and nitroprusside to adenosine for measurement of fractional flow reserve: A systematic review and meta-analysis.
    Cardiovascular revascularization medicine : including molecular interventions, 2018, Volume: 19, Issue:2

    Topics: Administration, Intravenous; Adult; Aged; Cardiac Catheterization; Coronary Artery Disease; Coronary Stenosis; Coronary Vessels; Female; Fractional Flow Reserve, Myocardial; Humans; Hyperemia; Male; Middle Aged; Nitroprusside; Predictive Value of Tests; Purines; Pyrazoles; Reproducibility of Results; Severity of Illness Index; Vasodilator Agents

2018
Incidence of atrioventricular block with vasodilator stress SPECT: A meta-analysis.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2019, Volume: 26, Issue:2

    Topics: Adenosine; Aged; Atrioventricular Block; Coronary Artery Disease; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Purines; Pyrazoles; Reproducibility of Results; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents

2019
Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledge.
    International journal of chronic obstructive pulmonary disease, 2014, Volume: 9

    Topics: Adenosine A2 Receptor Agonists; Asthma; Coronary Artery Disease; Echocardiography, Stress; Exercise Test; Humans; Lung; Myocardial Perfusion Imaging; Patient Selection; Predictive Value of Tests; Prognosis; Pulmonary Disease, Chronic Obstructive; Purines; Pyrazoles; Risk Factors; Severity of Illness Index; Vasodilator Agents

2014
Regadenoson stress for myocardial perfusion imaging.
    Future cardiology, 2016, Volume: 12, Issue:1

    Topics: Adenosine A2 Receptor Agonists; Coronary Artery Disease; Heart Function Tests; Humans; Myocardial Perfusion Imaging; Purines; Pyrazoles; Vasodilator Agents

2016
Regadenoson in the detection of coronary artery disease.
    Vascular health and risk management, 2008, Volume: 4, Issue:2

    Topics: Adenosine A2 Receptor Agonists; Animals; Contraindications; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Heart Function Tests; Humans; Hyperemia; Purines; Pyrazoles; Receptor, Adenosine A2A; Structure-Activity Relationship; Time Factors; Vasodilation; Vasodilator Agents

2008
Current advances in vasodilator pharmacological stress perfusion imaging.
    Seminars in nuclear medicine, 2009, Volume: 39, Issue:3

    Topics: Adenosine; Adult; Contraindications; Coronary Artery Disease; Dipyridamole; Exercise Test; Female; Humans; Myocardial Perfusion Imaging; Purines; Pyrazoles; Radiopharmaceuticals; Vasodilator Agents

2009
Regadenoson: a new myocardial stress agent.
    Journal of the American College of Cardiology, 2009, Sep-22, Volume: 54, Issue:13

    Topics: Blood Pressure; Coronary Artery Disease; Exercise Test; Heart Rate; Humans; Myocardial Perfusion Imaging; Purines; Pyrazoles; Vasodilator Agents

2009
Regadenoson: a focused update.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2013, Volume: 20, Issue:2

    Topics: Coronary Artery Disease; Evidence-Based Medicine; Exercise Test; Humans; Myocardial Perfusion Imaging; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents

2013
The future of pharmacologic stress: selective A2A adenosine receptor agonists.
    The American journal of cardiology, 2004, Jul-22, Volume: 94, Issue:2A

    Topics: Adenosine A2 Receptor Agonists; Animals; Clinical Trials as Topic; Coronary Artery Disease; Coronary Circulation; Forecasting; Humans; Purines; Pyrazoles; Receptor, Adenosine A2A; Stress, Physiological; Vasodilation

2004

Trials

13 trial(s) available for regadenoson and Arteriosclerosis, Coronary

ArticleYear
The Feasibility, Tolerability, Safety, and Accuracy of Low-radiation Dynamic Computed Tomography Myocardial Perfusion Imaging With Regadenoson Compared With Single-photon Emission Computed Tomography.
    Journal of thoracic imaging, 2021, Nov-01, Volume: 36, Issue:6

    Topics: Coronary Angiography; Coronary Artery Disease; Feasibility Studies; Female; Humans; Male; Myocardial Perfusion Imaging; Purines; Pyrazoles; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

2021
Randomized Comparison of Clinical Effectiveness of Pharmacologic SPECT and PET MPI in Symptomatic CAD Patients.
    JACC. Cardiovascular imaging, 2019, Volume: 12, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Agents; Comparative Effectiveness Research; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Coronary Stenosis; Dipyridamole; Female; Health Status; Humans; Kansas; Male; Middle Aged; Myocardial Perfusion Imaging; Myocardial Revascularization; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Purines; Pyrazoles; Referral and Consultation; Severity of Illness Index; Single Photon Emission Computed Tomography Computed Tomography; Time Factors; Treatment Outcome; Vasodilator Agents

2019
Safety and feasibility of adjunctive regadenoson injection at peak exercise during exercise myocardial perfusion imaging: The Both Exercise and Regadenoson Stress Test (BERST) trial.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2013, Volume: 20, Issue:2

    Topics: Adenosine A2 Receptor Agonists; Adult; Coronary Artery Disease; Exercise Test; Female; Humans; Image Enhancement; Male; Myocardial Perfusion Imaging; Physical Endurance; Physical Exertion; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents

2013
Stress positron emission tomography is safe and can guide coronary revascularization in high-risk patients being considered for transcatheter aortic valve replacement.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2014, Volume: 21, Issue:5

    Topics: Aged; Aortic Valve Stenosis; Coronary Artery Disease; Exercise Test; Female; Humans; Male; Myocardial Perfusion Imaging; Percutaneous Coronary Intervention; Positron-Emission Tomography; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; Surgery, Computer-Assisted; Transcatheter Aortic Valve Replacement; Vasodilator Agents

2014
Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: a quantitative analysis from the ADVANCE MPI trials.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2015, Volume: 22, Issue:2

    Topics: Adenosine; Adenosine A2 Receptor Agonists; Aged; Coronary Artery Disease; Double-Blind Method; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Myocardial Perfusion Imaging; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents; Ventricular Dysfunction, Left

2015
A useful and easy to develop combined stress test for myocardial perfusion imaging: Regadenoson and isometric exercise, preliminary results.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:1

    Topics: Aged; Coronary Artery Disease; Exercise Test; Female; Hand Strength; Humans; Image Enhancement; Isometric Contraction; Male; Myocardial Perfusion Imaging; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents

2017
The EXERRT trial: "EXErcise to Regadenoson in Recovery Trial": A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without exerc
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:3

    Topics: Coronary Artery Disease; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Purines; Pyrazoles; Recovery of Function; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; United States; Vasodilator Agents

2017
Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial.
    JACC. Cardiovascular imaging, 2009, Volume: 2, Issue:8

    Topics: Adenosine; Coronary Artery Disease; Coronary Circulation; Double-Blind Method; Heart Ventricles; Humans; Infusions, Intravenous; Linear Models; Myocardial Ischemia; Myocardial Perfusion Imaging; Predictive Value of Tests; Prospective Studies; Purines; Pyrazoles; Severity of Illness Index; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents; Ventricular Dysfunction, Left

2009
Safety of regadenoson in patients with end-stage liver disease.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2011, Volume: 18, Issue:1

    Topics: Adenosine A2 Receptor Antagonists; Aged; Comorbidity; Coronary Artery Disease; Drug-Related Side Effects and Adverse Reactions; Exercise Test; Female; Humans; Liver Diseases; Male; Ohio; Purines; Pyrazoles; Radionuclide Imaging; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Terminally Ill; Vasodilator Agents

2011
Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: rationale and design of a prospective, randomized, multicenter study.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2011, Volume: 18, Issue:1

    Topics: Adenosine A2 Receptor Antagonists; Administration, Oral; Adult; Aged; Aged, 80 and over; Caffeine; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Central Nervous System Stimulants; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Interactions; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Prevalence; Prospective Studies; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; United States; Young Adult

2011
A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2012, Volume: 19, Issue:2

    Topics: Adenosine A2 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Comorbidity; Coronary Artery Disease; Double-Blind Method; Drug Tolerance; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Placebo Effect; Prevalence; Purines; Pyrazoles; Radionuclide Imaging; Risk Assessment; Risk Factors; United States; Young Adult

2012
A strategy of symptom-limited exercise with regadenoson-as-needed for stress myocardial perfusion imaging: a randomized controlled trial.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2013, Volume: 20, Issue:2

    Topics: Adenosine A2 Receptor Agonists; Coronary Artery Disease; Exercise Test; Female; Humans; Image Enhancement; Male; Middle Aged; Myocardial Perfusion Imaging; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents

2013
Regadenoson pharmacologic stress for myocardial perfusion imaging: a three-way comparison between regadenoson administered at peak exercise, during walk recovery, or no-exercise.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2013, Volume: 20, Issue:2

    Topics: Adenosine A2 Receptor Agonists; Coronary Artery Disease; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Physical Endurance; Prevalence; Purines; Pyrazoles; Reproducibility of Results; Rest; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents; Walking

2013

Other Studies

60 other study(ies) available for regadenoson and Arteriosclerosis, Coronary

ArticleYear
Splenic switch-off in regadenoson
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:4

    Topics: Coronary Artery Disease; Female; Humans; Male; Myocardial Perfusion Imaging; Positron-Emission Tomography; Purines; Rubidium Radioisotopes

2023
Regadenoson Is All the RAGE: Targeting the Inflammatory Cascade in Primary Graft Dysfunction.
    The Annals of thoracic surgery, 2023, Volume: 116, Issue:6

    Topics: Coronary Artery Disease; Humans; Primary Graft Dysfunction; Purines; Vasodilator Agents

2023
PET myocardial perfusion imaging of regadenoson-induced coronary vasospasm.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:5

    Topics: Coronary Artery Disease; Coronary Vasospasm; Humans; Myocardial Perfusion Imaging; Purines; Tomography, Emission-Computed, Single-Photon

2023
What is this image? 2023 image 2 results: In vivo demonstration of regadenoson-induced severe ischemia on PET myocardial perfusion imaging in a patient with hypertrophic obstructive cardiomyopathy and nonobstructive coronary artery disease.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:5

    Topics: Cardiomyopathy, Hypertrophic; Coronary Artery Disease; Humans; Ischemia; Myocardial Perfusion Imaging

2023
Feasibility and accuracy of SPECT myocardial perfusion imaging in end-stage lung disease.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020, Volume: 27, Issue:3

    Topics: Aged; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Myocardial Perfusion Imaging; Percutaneous Coronary Intervention; Purines; Pyrazoles; Reproducibility of Results; Retrospective Studies; Tomography, Emission-Computed, Single-Photon

2020
Are Patients With End-Stage Liver Disease Maximally Vasodilated?: Insights From Rubidium-82 PET Dilatory Perfusion.
    JACC. Cardiovascular imaging, 2019, Volume: 12, Issue:12

    Topics: Aged; Coronary Artery Disease; Dipyridamole; End Stage Liver Disease; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Purines; Pyrazoles; Radiopharmaceuticals; Retrospective Studies; Rubidium Radioisotopes; Vasodilation; Vasodilator Agents

2019
Regadenoson myocardial perfusion scintigraphy for the evaluation of coronary artery disease in patients with lung disease: A series of five cases.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020, Volume: 27, Issue:1

    Topics: Adenosine A2 Receptor Agonists; Aged; Coronary Artery Disease; Female; Humans; Lung Diseases; Male; Middle Aged; Myocardial Perfusion Imaging; Purines; Pyrazoles; Tomography, Emission-Computed, Single-Photon

2020
Safety of regadenoson with theophylline reversal during dynamic computed tomography perfusion and magnetic resonance imaging in patients with coronary artery disease.
    Kardiologia polska, 2020, 08-25, Volume: 78, Issue:7-8

    Topics: Coronary Artery Disease; Female; Humans; Magnetic Resonance Imaging; Myocardial Perfusion Imaging; Perfusion; Prospective Studies; Purines; Pyrazoles; Theophylline; Tomography, Emission-Computed, Single-Photon

2020
Regadenoson-induced T-wave heterogeneity complements coronary stenosis detection by myocardial perfusion imaging in men and women.
    European heart journal. Cardiovascular Imaging, 2021, 10-19, Volume: 22, Issue:11

    Topics: Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Female; Humans; Male; Myocardial Perfusion Imaging; Purines; Pyrazoles

2021
The prognostic implications of ST-segment and T-wave abnormalities in patients undergoing regadenoson stress SPECT myocardial perfusion imaging.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:2

    Topics: Coronary Artery Disease; Humans; Myocardial Ischemia; Myocardial Perfusion Imaging; Prognosis; Purines; Pyrazoles; Retrospective Studies; Tomography, Emission-Computed, Single-Photon

2022
Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:1

    Topics: Adenosine; Arteries; Coronary Artery Disease; Coronary Circulation; Humans; Hyperemia; Myocardial Perfusion Imaging; Perfusion; Positron-Emission Tomography; Purines; Pyrazoles; Water

2022
Left ventricular ejection fraction, myocardial blood flow and hemodynamic variables in adenosine and regadenoson vasodilator 82-Rubidium PET.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:3

    Topics: Adenosine; Coronary Artery Disease; Coronary Circulation; Hemodynamics; Humans; Myocardial Perfusion Imaging; Positron-Emission Tomography; Purines; Pyrazoles; Rubidium; Stroke Volume; Vasodilator Agents; Ventricular Function, Left

2022
Clinical experience with regadenoson SPECT myocardial perfusion imaging: insights into patient characteristics, safety, and impact of results on clinical management.
    The international journal of cardiovascular imaging, 2022, Volume: 38, Issue:1

    Topics: Adolescent; Aged; Coronary Artery Disease; Exercise Test; Female; Humans; Male; Myocardial Perfusion Imaging; Perfusion; Predictive Value of Tests; Purines; Pyrazoles; Tomography, Emission-Computed, Single-Photon

2022
Rapid rest/stress regadenoson ungated perfusion CMR for detection of coronary artery disease in patients with atrial fibrillation.
    The international journal of cardiovascular imaging, 2017, Volume: 33, Issue:11

    Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Female; Heart Rate; Humans; Hyperemia; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Perfusion Imaging; Predictive Value of Tests; Purines; Pyrazoles; Reproducibility of Results; Time Factors; Vasodilator Agents

2017
Effects of caffeine intake prior to stress cardiac magnetic resonance perfusion imaging on regadenoson- versus adenosine-induced hyperemia as measured by T1 mapping.
    The international journal of cardiovascular imaging, 2017, Volume: 33, Issue:11

    Topics: Adenosine; Aged; Caffeine; Coffee; Coronary Artery Disease; Coronary Circulation; Female; Humans; Hyperemia; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Perfusion Imaging; Predictive Value of Tests; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purines; Pyrazoles; Reproducibility of Results; Time Factors; Vasodilator Agents

2017
Quantitative cardiovascular magnetic resonance perfusion imaging identifies reduced flow reserve in microvascular coronary artery disease.
    Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2018, 02-22, Volume: 20, Issue:1

    Topics: Adult; Aged; Blood Flow Velocity; Case-Control Studies; Computed Tomography Angiography; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Female; Fractional Flow Reserve, Myocardial; Humans; Magnetic Resonance Imaging, Cine; Male; Microcirculation; Middle Aged; Myocardial Perfusion Imaging; Predictive Value of Tests; Purines; Pyrazoles; Vasodilator Agents

2018
CMR stress testing in a patient with morbid obesity (BMI 58 kg/m
    BMC cardiovascular disorders, 2018, 03-05, Volume: 18, Issue:1

    Topics: Body Mass Index; Coronary Artery Disease; Coronary Circulation; Coronary Stenosis; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Myocardial Perfusion Imaging; Obesity, Morbid; Predictive Value of Tests; Prognosis; Purines; Pyrazoles; Risk Factors; Vasodilator Agents

2018
Fully quantitative pixel-wise analysis of cardiovascular magnetic resonance perfusion improves discrimination of dark rim artifact from perfusion defects associated with epicardial coronary stenosis.
    Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2018, 03-08, Volume: 20, Issue:1

    Topics: Adult; Aged; Artifacts; Blood Flow Velocity; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Coronary Stenosis; Coronary Vessels; Female; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Perfusion Imaging; Predictive Value of Tests; Purines; Pyrazoles; Reproducibility of Results; Retrospective Studies; Severity of Illness Index; Vasodilator Agents

2018
Relationship of
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020, Volume: 27, Issue:2

    Topics: Aged; Algorithms; Angiography; Area Under Curve; Constriction, Pathologic; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Female; Heart; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Myocardium; Positron Emission Tomography Computed Tomography; Purines; Pyrazoles; Retrospective Studies; Rubidium Radioisotopes

2020
Feasibility, safety and effectiveness in measuring microvascular resistance with regadenoson.
    Clinical hemorheology and microcirculation, 2019, Volume: 71, Issue:3

    Topics: Adenosine A2 Receptor Agonists; Aged; Coronary Artery Disease; Feasibility Studies; Female; Fractional Flow Reserve, Myocardial; Humans; Male; Microcirculation; Purines; Pyrazoles

2019
Pituitary apoplexy after regadenoson myocardial perfusion scan.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020, Volume: 27, Issue:1

    Topics: Adenosine A2 Receptor Agonists; Coronary Artery Disease; Female; Humans; Middle Aged; Myocardial Perfusion Imaging; Pituitary Apoplexy; Purines; Pyrazoles; Tomography, Emission-Computed, Single-Photon

2020
Safety and prognostic value of regadenoson stress cardiovascular magnetic resonance imaging in heart transplant recipients.
    Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2019, 01-24, Volume: 21, Issue:1

    Topics: Adult; Coronary Artery Disease; Female; Heart Transplantation; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Predictive Value of Tests; Purines; Pyrazoles; Reoperation; Retrospective Studies; Risk Factors; Treatment Outcome; Vasodilator Agents

2019
Marked multi-distribution myocardial ischemia in a patient with hypertrophic cardiomyopathy and no obstructive coronary artery disease.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020, Volume: 27, Issue:2

    Topics: Cardiac Catheterization; Cardiomyopathy, Hypertrophic; Coronary Artery Disease; Electrocardiography; Female; Humans; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Purines; Pyrazoles; Systole; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left

2020
Regadenoson-induced asystole and ischemic EKG changes in the setting of underlying coronary disease.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020, Volume: 27, Issue:2

    Topics: Aged; Bradycardia; Cardiology; Coronary Artery Disease; Echocardiography; Heart Arrest; Hemodynamics; Humans; Ischemia; Male; Purines; Pyrazoles

2020
Risk stratification with vasodilator stress SPECT myocardial perfusion imaging in patients with elevated cardiac biomarkers.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020, Volume: 27, Issue:6

    Topics: Aged; Biomarkers; Coronary Artery Disease; Exercise Test; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardial Perfusion Imaging; Perfusion; Prognosis; Proportional Hazards Models; Purines; Pyrazoles; Risk Assessment; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Vasodilator Agents

2020
Initial experience with regadenoson stress positron emission tomography in patients with left bundle branch block: Low prevalence of septal defects and high accuracy for obstructive coronary artery disease.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2021, Volume: 28, Issue:2

    Topics: Aged; Aged, 80 and over; Bundle-Branch Block; Coronary Artery Disease; Female; Heart Septum; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Positron-Emission Tomography; Purines; Pyrazoles; Tomography, Emission-Computed, Single-Photon

2021
Marked ST-segment elevations during regadenoson pharmacologic nuclear stress testing.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020, Volume: 27, Issue:3

    Topics: Aged; Angioplasty, Balloon; Coronary Angiography; Coronary Artery Disease; Electrocardiography; Exercise Test; Humans; Male; Myocardial Ischemia; Myocardial Perfusion Imaging; Purines; Pyrazoles; Tomography, Emission-Computed, Single-Photon

2020
Prognostic Implications of Blunted Feature-Tracking Global Longitudinal Strain During Vasodilator Cardiovascular Magnetic Resonance Stress Imaging.
    JACC. Cardiovascular imaging, 2020, Volume: 13, Issue:1 Pt 1

    Topics: Aged; Coronary Artery Disease; Coronary Circulation; Female; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Observer Variation; Predictive Value of Tests; Progression-Free Survival; Prospective Studies; Purines; Pyrazoles; Reproducibility of Results; Risk Assessment; Risk Factors; Stroke Volume; Time Factors; Vasodilation; Vasodilator Agents; Ventricular Function, Left

2020
Coronary Microvascular Dysfunction by Myocardial Contrast Echocardiography in Nonelderly Patients Referred for Computed Tomographic Coronary Angiography.
    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2019, Volume: 32, Issue:7

    Topics: Adult; Brachial Artery; Chest Pain; Computed Tomography Angiography; Coronary Artery Disease; Echocardiography; Female; Humans; Iohexol; Male; Microvascular Angina; Middle Aged; Oregon; Prospective Studies; Purines; Pyrazoles

2019
Regadenoson Stress Perfusion Cardiac Magnetic Resonance Imaging in Children With Kawasaki Disease and Coronary Artery Disease.
    The American journal of cardiology, 2019, 10-01, Volume: 124, Issue:7

    Topics: Adenosine A2 Receptor Agonists; Adolescent; Child; Child, Preschool; Coronary Artery Disease; Cross-Sectional Studies; Female; Humans; Infant; Magnetic Resonance Imaging; Male; Mucocutaneous Lymph Node Syndrome; Myocardial Perfusion Imaging; Purines; Pyrazoles; Retrospective Studies

2019
Detection of obstructive coronary artery disease using regadenoson stress and 82Rb PET/CT myocardial perfusion imaging.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:10

    Topics: Aged; Coronary Angiography; Coronary Artery Disease; Humans; Male; Middle Aged; Multimodal Imaging; Myocardial Perfusion Imaging; Positron-Emission Tomography; Purines; Pyrazoles; Rubidium Radioisotopes; Stress, Physiological; Stroke Volume; Tomography, X-Ray Computed; Vasodilator Agents; Ventricular Dysfunction, Left

2013
Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance.
    Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2013, Dec-21, Volume: 15

    Topics: Adult; Aged; Contrast Media; Coronary Artery Disease; Female; Gadolinium DTPA; Hemodynamics; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Infarction; Myocardial Perfusion Imaging; Myocardial Revascularization; Perfusion; Predictive Value of Tests; Prognosis; Purines; Pyrazoles; Risk Factors; Stroke Volume; Time Factors; Vasodilator Agents; Ventricular Function, Left

2013
Feasibility, safety and accuracy of regadenoson-atropine (REGAT) stress echocardiography for the diagnosis of coronary artery disease: an angiographic correlative study.
    The international journal of cardiovascular imaging, 2014, Volume: 30, Issue:3

    Topics: Adenosine A2 Receptor Agonists; Anti-Arrhythmia Agents; Atropine; Coronary Angiography; Coronary Artery Disease; Dyspnea; Echocardiography, Stress; Feasibility Studies; Female; Headache; Humans; Male; Middle Aged; Patient Satisfaction; Predictive Value of Tests; Prospective Studies; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; Surveys and Questionnaires

2014
Asystole following regadenoson infusion in stable outpatients.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2014, Volume: 21, Issue:5

    Topics: Adenosine A2 Receptor Agonists; Aged; Ambulatory Care; Coronary Artery Disease; Exercise Test; Female; Heart Arrest; Humans; Infusions, Intravenous; Male; Myocardial Perfusion Imaging; Purines; Pyrazoles; Vasodilator Agents

2014
Regadenoson for myocardial perfusion imaging: Is it safe?
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2014, Volume: 21, Issue:5

    Topics: Adenosine A2 Receptor Agonists; Coronary Artery Disease; Exercise Test; Female; Heart Arrest; Humans; Male; Myocardial Perfusion Imaging; Purines; Pyrazoles; Vasodilator Agents

2014
Incremental value of pharmacological stress cardiac dual-energy CT over coronary CT angiography alone for the assessment of coronary artery disease in a high-risk population.
    AJR. American journal of roentgenology, 2014, Volume: 203, Issue:1

    Topics: Adenosine; Cardiac Catheterization; Cardiac-Gated Imaging Techniques; Contrast Media; Coronary Angiography; Coronary Artery Disease; Exercise Test; Female; Humans; Iopamidol; Male; Middle Aged; Prospective Studies; Purines; Pyrazoles; Radiation Dosage; Radiographic Image Interpretation, Computer-Assisted; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

2014
Serious complications associated with regadenoson administration for myocardial perfusion imaging: a commentary.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2014, Volume: 21, Issue:5

    Topics: Adenosine A2 Receptor Agonists; Atropine; Bradycardia; Coronary Artery Disease; Exercise Test; Female; Heart Arrest; Humans; Hypotension; Male; Myocardial Perfusion Imaging; Purines; Pyrazoles; Vasodilator Agents

2014
Variability of fractional flow reserve according to the methods of hyperemia induction.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2015, Volume: 85, Issue:6

    Topics: Adenosine; Aged; Coronary Artery Disease; Coronary Circulation; Female; Fractional Flow Reserve, Myocardial; Hemodynamics; Humans; Hyperemia; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Middle Aged; Nicorandil; Purines; Pyrazoles; Radiography; Reproducibility of Results; Vasodilator Agents

2015
The prognostic value of regadenoson myocardial perfusion imaging.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2015, Volume: 22, Issue:6

    Topics: Adenosine A2 Receptor Agonists; Coronary Artery Disease; Death, Sudden, Cardiac; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Prevalence; Prognosis; Purines; Pyrazoles; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed, Single-Photon; United States

2015
The significance of automatically measured transient ischemic dilation in identifying severe and extensive coronary artery disease in regadenoson, single-isotope technetium-99m myocardial perfusion SPECT.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2015, Volume: 22, Issue:3

    Topics: Aged; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Exercise Test; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Myocardial Perfusion Imaging; Pattern Recognition, Automated; Prevalence; Purines; Pyrazoles; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Rest; ROC Curve; Technetium; Tomography, Emission-Computed, Single-Photon

2015
Comparison of the prognostic value of regadenoson and adenosine myocardial perfusion imaging.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2015, Volume: 22, Issue:4

    Topics: Adenosine; Coronary Artery Disease; Death, Sudden, Cardiac; Exercise Test; Female; Humans; Incidence; Male; Middle Aged; Myocardial Perfusion Imaging; North Carolina; Prevalence; Prognosis; Purines; Pyrazoles; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Vasodilator Agents

2015
Effect of changes in perfusion defect size during serial regadenoson myocardial perfusion imaging on cardiovascular outcomes in high-risk patients.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2016, Volume: 23, Issue:1

    Topics: Alabama; Comorbidity; Contrast Media; Coronary Artery Disease; Exercise Test; Female; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Myocardial Infarction; Myocardial Perfusion Imaging; Percutaneous Coronary Intervention; Prevalence; Prognosis; Purines; Pyrazoles; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Survival Rate; Vasodilator Agents

2016
EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision.
    European journal of nuclear medicine and molecular imaging, 2015, Volume: 42, Issue:12

    Topics: Adult; Contrast Media; Coronary Artery Disease; Dose-Response Relationship, Drug; Exercise; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Myocardial Perfusion Imaging; Practice Guidelines as Topic; Purines; Pyrazoles; Radiation Exposure; Safety; Societies, Medical; Software; Tomography, X-Ray Computed; Vasodilator Agents

2015
Regadenoson Stress Real-Time Myocardial Perfusion Echocardiography for Detection of Coronary Artery Disease: Feasibility and Accuracy of Two Different Ultrasound Contrast Agents.
    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2015, Volume: 28, Issue:12

    Topics: Adenosine A2 Receptor Agonists; Contrast Media; Coronary Angiography; Coronary Artery Disease; Echocardiography, Stress; Feasibility Studies; Female; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Perfusion Imaging; Purines; Pyrazoles; Reproducibility of Results

2015
ST Segment Elevation ECG Changes During Pharmacologic Stress With Regadenoson.
    Clinical nuclear medicine, 2016, Volume: 41, Issue:1

    Topics: Adenosine A2 Receptor Agonists; Coronary Angiography; Coronary Artery Disease; Electrocardiography; Exercise Test; Heart Rate; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Purines; Pyrazoles; Tomography, Emission-Computed, Single-Photon

2016
Prognostic impact of TID in regadenoson MPI: Some patients and certain events.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2016, Volume: 23, Issue:5

    Topics: Coronary Artery Disease; Exercise Test; Humans; Myocardial Perfusion Imaging; Prognosis; Purines; Pyrazoles; Tomography, Emission-Computed, Single-Photon

2016
The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:1

    Topics: Age Distribution; Cardio-Renal Syndrome; Chicago; Comorbidity; Coronary Artery Disease; Death, Sudden, Cardiac; Exercise Test; Female; Humans; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Perfusion Imaging; Prognosis; Purines; Pyrazoles; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Sex Distribution; Single-Blind Method; Survival Rate; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents

2017
Safety and tolerability of regadenoson for myocardial perfusion imaging - first Danish experience.
    Scandinavian cardiovascular journal : SCJ, 2016, Volume: 50, Issue:3

    Topics: Adenosine A2 Receptor Agonists; Aged; Coronary Artery Disease; Denmark; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Outcome and Process Assessment, Health Care; Purines; Pyrazoles; Tomography, Emission-Computed, Single-Photon

2016
The reproducibility and prognostic value of serial measurements of heart rate response to regadenoson during myocardial perfusion imaging.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:8

    Topics: Coronary Artery Disease; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Prognosis; Purines; Pyrazoles; Reproducibility of Results; Time Factors; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents

2016
Computer derived transient ischemic dilation ratio for identifying extensive coronary artery disease using a CZT camera and imaging in the upright position.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:5

    Topics: Aged; Cadmium; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Diagnosis, Computer-Assisted; Dilatation; Exercise Test; Female; Heart Ventricles; Humans; Image Processing, Computer-Assisted; Ischemia; Male; Middle Aged; Myocardial Perfusion Imaging; Predictive Value of Tests; Purines; Pyrazoles; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tellurium; Tomography, Emission-Computed, Single-Photon; Zinc

2017
Quantitation of left ventricular ejection fraction reserve from early gated regadenoson stress Tc-99m high-efficiency SPECT.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2016, Volume: 23, Issue:6

    Topics: Aged; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Coronary Artery Disease; Exercise Test; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Purines; Pyrazoles; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents; Ventricular Dysfunction, Left

2016
Impact of Stress Cardiac Magnetic Resonance Imaging on Clinical Care.
    The American journal of cardiology, 2016, 09-15, Volume: 118, Issue:6

    Topics: Adenosine A2 Receptor Agonists; Aged; Aminophylline; Cardiotonic Agents; Clinical Decision-Making; Contrast Media; Coronary Artery Disease; Disease Management; Exercise Test; Female; Gadolinium; Heterocyclic Compounds; Humans; Logistic Models; Magnetic Resonance Imaging; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Myocardial Perfusion Imaging; Odds Ratio; Organometallic Compounds; Patient Selection; Prospective Studies; Purines; Pyrazoles

2016
Safety of regadenoson stress testing in patients with pulmonary hypertension.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2018, Volume: 25, Issue:3

    Topics: Adenosine A2 Receptor Agonists; Aged; Blood Pressure; Coronary Artery Disease; Dyspnea; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Hypertension, Pulmonary; Male; Middle Aged; Myocardial Perfusion Imaging; Positron-Emission Tomography; Purines; Pyrazoles; Retrospective Studies; Tomography, Emission-Computed, Single-Photon

2018
Regadenoson.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2010, Volume: 10, Issue:1

    Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Coronary Artery Disease; Coronary Circulation; Humans; Myocardial Perfusion Imaging; Purines; Pyrazoles

2010
Outcome of patients with regadenoson-induced ST-segment depression but normal perfusion on single-photon emission computed tomography.
    Angiology, 2013, Volume: 64, Issue:1

    Topics: Aged; Aged, 80 and over; Coronary Artery Disease; Electrocardiography; Exercise Test; Female; Follow-Up Studies; Humans; Male; Myocardial Perfusion Imaging; Prognosis; Purines; Pyrazoles; Risk Assessment; Survival Rate; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents

2013
Assessment of transient ischemic dilation (TID) ratio in gated SPECT myocardial perfusion imaging (MPI) using regadenoson, a new agent for pharmacologic stress testing.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2012, Volume: 19, Issue:4

    Topics: Adenosine A2 Receptor Agonists; Aged; Aged, 80 and over; Angiography; Coronary Angiography; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Odds Ratio; Purines; Pyrazoles; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Software; Tomography, Emission-Computed, Single-Photon

2012
Off-label, but on-target: use of regadenoson with exercise.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2013, Volume: 20, Issue:2

    Topics: Coronary Artery Disease; Exercise Test; Female; Humans; Image Enhancement; Male; Myocardial Perfusion Imaging; Purines; Pyrazoles; Tomography, Emission-Computed, Single-Photon

2013
Safety and tolerability of regadenoson in 514 SPECT MPI patients with and without coronary artery disease and submaximal exercise heart rate response.
    European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:3

    Topics: Cohort Studies; Coronary Artery Disease; Exercise Test; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Purines; Pyrazoles; Retrospective Studies; Safety; Tomography, Emission-Computed, Single-Photon; Treatment Outcome

2013
Myocardial perfusion imaging laboratory efficiency with the use of regadenoson compared to adenosine and dipyridamole.
    Journal of medical economics, 2013, Volume: 16, Issue:4

    Topics: Adenosine; Coronary Artery Disease; Data Collection; Dipyridamole; Health Personnel; Humans; Myocardial Perfusion Imaging; Nuclear Medicine Department, Hospital; Purines; Pyrazoles; Receptor, Adenosine A2A; Time Factors; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents

2013
Regadenoson (CV Therapeutics/Astellas).
    Current opinion in investigational drugs (London, England : 2000), 2006, Volume: 7, Issue:3

    Topics: Adenosine A2 Receptor Agonists; Clinical Trials, Phase III as Topic; Coronary Artery Disease; Humans; Purines; Pyrazoles; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Vasodilation; Vasodilator Agents

2006